Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema

As enhanced S100A4 expression was observed in remodeled intrapulmonary arteries of COPD patients, targeting S100A4 could serve as potential therapeutic option for prevention of vascular remodeling in COPD patients.